4//SEC Filing
Abrahmsen Lars B. 4
Accession 0001104659-20-038879
CIK 0001781983other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 5:01 PM ET
Size
5.4 KB
Accession
0001104659-20-038879
Insider Transaction Report
Form 4
Abrahmsen Lars B.
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (right to Buy)
2020-03-24+31,600→ 31,600 totalExercise: $35.50Exp: 2030-03-24→ Common Stock (31,600 underlying)
Footnotes (1)
- [F1]Twenty-five percent of these options vest on March 24, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001789039
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 5:01 PM ET
- Size
- 5.4 KB